Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Of Ergocalciferol In Adults According To BMI

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Study subjects have to be between the ages of 18 to 65 with a serum 25OHD level less than 20 ng/ml.~Exclusion Criteria:~* Participants will be excluded if they have any of the following:~  1. Due to the inaccuracies of BMI in patients with increased muscle mass, in group with a BMI 25-35: men with a waist circumference \< 90 cm ; women \< 80 cm~ 2. Chronic liver disease defined by any clinical or a history of serum AST or ALT \> 2 times ULN~ 3. Kidney disease defined as a GFR \<60 ml/min~ 4. Sarcoidosis~ 5. Any known malignancy~ 6. Known malabsorption disorder to include inflammatory bowel disease, celiac disease, cystic fibrosis, history of gastric bypass~ 7. Primary hyperparathyroidism or hypercalcemia,~ 8. Patients that are pregnant or considering pregnancy.~ 9. Patients taking certain medications such as glucocorticoids, anti-seizure medications such has phenobarbital or phenytoin or patients taking antiviral medications for HIV as these are known to cause vitamin D deficiency~ 10. Individuals excluded from having a DXA scan~Study participants will be excluded from having a DXA scan if any of the following:~1. Any amputation of a extremity including toes~2. If they have a pacemaker, automatic defibrillator, coronary stents or metal suture material in the heart~3. If they have artificial joints, pins, plate or any other type of metal objects~4. If they have received contrast material such as barium in the past 7 days~5. If they have had a nuclear medicine study in the past 3 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- BMI <25 (Type: EXPERIMENTAL): Normal BMI
- BMI 25-35 (Type: EXPERIMENTAL): Overweight and obese by BMI
- BMI >35 (Type: EXPERIMENTAL): Obese by BMI

Based on this trial design, predict the completion outcome and termination type (if applicable).